Recombinant Protein Drug RD and Forecast Market

List of Tables
Table 1. Recombinant Protein Drug R&D Market Opportunities & Trends in Global Market
Table 2. Recombinant Protein Drug R&D Market Drivers in Global Market
Table 3. Recombinant Protein Drug R&D Market Restraints in Global Market
Table 4. Key Players of Recombinant Protein Drug R&D in Global Market
Table 5. Top Recombinant Protein Drug R&D Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Recombinant Protein Drug R&D Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Recombinant Protein Drug R&D Revenue Share by Companies, 2017-2022
Table 8. Global Companies Recombinant Protein Drug R&D Product Type
Table 9. List of Global Tier 1 Recombinant Protein Drug R&D Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Protein Drug R&D Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Recombinant Protein Drug R&D Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Recombinant Protein Drug R&D Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Recombinant Protein Drug R&D Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Recombinant Protein Drug R&D Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Recombinant Protein Drug R&D Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Recombinant Protein Drug R&D Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Recombinant Protein Drug R&D Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Recombinant Protein Drug R&D Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Recombinant Protein Drug R&D Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Recombinant Protein Drug R&D Product Offerings
Table 32. Eli Lilly Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 33. Novo Nordisk Corporate Summary
Table 34. Novo Nordisk Recombinant Protein Drug R&D Product Offerings
Table 35. Novo Nordisk Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Recombinant Protein Drug R&D Product Offerings
Table 38. Amgen Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Recombinant Protein Drug R&D Product Offerings
Table 41. Merck Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Recombinant Protein Drug R&D Product Offerings
Table 44. Sanofi Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Recombinant Protein Drug R&D Product Offerings
Table 47. Pfizer Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Recombinant Protein Drug R&D Product Offerings
Table 50. Roche Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 51. Gensci Corporate Summary
Table 52. Gensci Recombinant Protein Drug R&D Product Offerings
Table 53. Gensci Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 54. Ankebio Corporate Summary
Table 55. Ankebio Recombinant Protein Drug R&D Product Offerings
Table 56. Ankebio Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 57. United Cell Corporate Summary
Table 58. United Cell Recombinant Protein Drug R&D Product Offerings
Table 59. United Cell Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 60. Sinobioway Hygene Corporate Summary
Table 61. Sinobioway Hygene Recombinant Protein Drug R&D Product Offerings
Table 62. Sinobioway Hygene Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 63. Kexing Corporate Summary
Table 64. Kexing Recombinant Protein Drug R&D Product Offerings
Table 65. Kexing Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 66. Dongbao Corporate Summary
Table 67. Dongbao Recombinant Protein Drug R&D Product Offerings
Table 68. Dongbao Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 69. 3sbio Corporate Summary
Table 70. 3sbio Recombinant Protein Drug R&D Product Offerings
Table 71. 3sbio Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 72. Gan&Lee Corporate Summary
Table 73. Gan&Lee Recombinant Protein Drug R&D Product Offerings
Table 74. Gan&Lee Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 75. Hengrui Corporate Summary
Table 76. Hengrui Recombinant Protein Drug R&D Product Offerings
Table 77. Hengrui Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Recombinant Protein Drug R&D Segment by Type in 2021
Figure 2. Recombinant Protein Drug R&D Segment by Application in 2021
Figure 3. Global Recombinant Protein Drug R&D Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Protein Drug R&D Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Protein Drug R&D Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Protein Drug R&D Revenue in 2021
Figure 8. By Type - Global Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 9. By Application - Global Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 10. By Region - Global Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 11. By Country - North America Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 12. US Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 16. Germany Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 17. France Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 24. China Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 28. India Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 30. Brazil Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 33. Turkey Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novo Nordisk Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gensci Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ankebio Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. United Cell Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sinobioway Hygene Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Kexing Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Dongbao Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. 3sbio Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Gan&Lee Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Hengrui Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)